"Receptors, Dopamine D1" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A subfamily of G-PROTEIN-COUPLED RECEPTORS that bind the neurotransmitter DOPAMINE and modulate its effects. D1-class receptor genes lack INTRONS, and the receptors stimulate ADENYLYL CYCLASES.
Descriptor ID |
D017447
|
MeSH Number(s) |
D12.776.543.750.670.300.400.400 D12.776.543.750.695.150.400.400 D12.776.543.750.720.330.400.400
|
Concept/Terms |
Receptors, Dopamine D1- Receptors, Dopamine D1
- Dopamine-D1 Receptor
- Dopamine D1 Receptor
- Receptor, Dopamine-D1
- Dopamine D1 Receptors
- D1 Receptors, Dopamine
|
Below are MeSH descriptors whose meaning is more general than "Receptors, Dopamine D1".
- Chemicals and Drugs [D]
- Amino Acids, Peptides, and Proteins [D12]
- Proteins [D12.776]
- Membrane Proteins [D12.776.543]
- Receptors, Cell Surface [D12.776.543.750]
- Receptors, Biogenic Amine [D12.776.543.750.670]
- Receptors, Catecholamine [D12.776.543.750.670.300]
- Receptors, Dopamine [D12.776.543.750.670.300.400]
- Receptors, Dopamine D1 [D12.776.543.750.670.300.400.400]
- Receptors, G-Protein-Coupled [D12.776.543.750.695]
- Receptors, Catecholamine [D12.776.543.750.695.150]
- Receptors, Dopamine [D12.776.543.750.695.150.400]
- Receptors, Dopamine D1 [D12.776.543.750.695.150.400.400]
- Receptors, Neurotransmitter [D12.776.543.750.720]
- Receptors, Catecholamine [D12.776.543.750.720.330]
- Receptors, Dopamine [D12.776.543.750.720.330.400]
- Receptors, Dopamine D1 [D12.776.543.750.720.330.400.400]
Below are MeSH descriptors whose meaning is more specific than "Receptors, Dopamine D1".
This graph shows the total number of publications written about "Receptors, Dopamine D1" by people in this website by year, and whether "Receptors, Dopamine D1" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1993 | 2 | 0 | 2 |
1994 | 2 | 1 | 3 |
1995 | 1 | 2 | 3 |
1996 | 1 | 2 | 3 |
1997 | 3 | 0 | 3 |
1998 | 1 | 2 | 3 |
1999 | 1 | 0 | 1 |
2000 | 1 | 0 | 1 |
2001 | 4 | 0 | 4 |
2002 | 0 | 1 | 1 |
2004 | 2 | 0 | 2 |
2005 | 1 | 1 | 2 |
2006 | 1 | 2 | 3 |
2007 | 2 | 2 | 4 |
2008 | 0 | 3 | 3 |
2009 | 1 | 0 | 1 |
2010 | 1 | 1 | 2 |
2012 | 0 | 1 | 1 |
2013 | 2 | 0 | 2 |
2015 | 1 | 0 | 1 |
2016 | 0 | 1 | 1 |
2018 | 0 | 2 | 2 |
2019 | 1 | 0 | 1 |
2020 | 1 | 0 | 1 |
2021 | 1 | 1 | 2 |
2022 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Receptors, Dopamine D1" by people in Profiles.
-
Armenta-Resendiz M, Assali A, Tsvetkov E, Cowan CW, Lavin A. Repeated methamphetamine administration produces cognitive deficits through augmentation of GABAergic synaptic transmission in the prefrontal cortex. Neuropsychopharmacology. 2022 09; 47(10):1816-1825.
-
Kruyer A, Parrilla-Carrero J, Powell C, Brandt L, Gutwinski S, Angelis A, Chalhoub RM, Jhou TC, Kalivas PW, Amato D. Accumbens D2-MSN hyperactivity drives antipsychotic-induced behavioral supersensitivity. Mol Psychiatry. 2021 11; 26(11):6159-6169.
-
Nimitvilai-Roberts S, Gioia D, Zamudio PA, Woodward JJ. Ethanol inhibition of lateral orbitofrontal cortex neuron excitability is mediated via dopamine D1/D5 receptor-induced release of astrocytic glycine. Neuropharmacology. 2021 07 01; 192:108600.
-
Garcia-Keller C, Scofield MD, Neuhofer D, Varanasi S, Reeves MT, Hughes B, Anderson E, Richie CT, Mejias-Aponte C, Pickel J, Hope BT, Harvey BK, Cowan CW, Kalivas PW. Relapse-Associated Transient Synaptic Potentiation Requires Integrin-Mediated Activation of Focal Adhesion Kinase and Cofilin in D1-Expressing Neurons. J Neurosci. 2020 10 28; 40(44):8463-8477.
-
Pardo-Garcia TR, Garcia-Keller C, Penaloza T, Richie CT, Pickel J, Hope BT, Harvey BK, Kalivas PW, Heinsbroek JA. Ventral Pallidum Is the Primary Target for Accumbens D1 Projections Driving Cocaine Seeking. J Neurosci. 2019 03 13; 39(11):2041-2051.
-
Kalivas PW. Deconstructing and Reconstructing the Dichotomy That Is Dopamine Receptor-1- and Dopamine Receptor-2-Expressing Neurons. Biol Psychiatry. 2018 12 15; 84(12):862-864.
-
Roberts-Wolfe D, Bobadilla AC, Heinsbroek JA, Neuhofer D, Kalivas PW. Drug Refraining and Seeking Potentiate Synapses on Distinct Populations of Accumbens Medium Spiny Neurons. J Neurosci. 2018 08 08; 38(32):7100-7107.
-
Schacht JP. COMT val158met moderation of dopaminergic drug effects on cognitive function: a critical review. Pharmacogenomics J. 2016 10; 16(5):430-8.
-
Kupchik YM, Brown RM, Heinsbroek JA, Lobo MK, Schwartz DJ, Kalivas PW. Coding the direct/indirect pathways by D1 and D2 receptors is not valid for accumbens projections. Nat Neurosci. 2015 Sep; 18(9):1230-2.
-
Hobson BD, O'Neill CE, Levis SC, Monteggia LM, Neve RL, Self DW, Bachtell RK. Adenosine A1 and dopamine d1 receptor regulation of AMPA receptor phosphorylation and cocaine-seeking behavior. Neuropsychopharmacology. 2013 Sep; 38(10):1974-83.